Exciting evidence has qualified sphingolipids as potential drivers of renal pathology, with implicated roles in multiple features of DKD including altered lipid metabolism, insulin resistance, mitochondrial dysfunction, fibrosis, apoptosis, and vascular damage. The gene discussed is INS; the disease is diabetic kidney disease.